Bleakley Financial Group LLC Has $2.04 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Bleakley Financial Group LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 88.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,016 shares of the company's stock after selling 37,015 shares during the quarter. Bleakley Financial Group LLC's holdings in HCA Healthcare were worth $2,039,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. CreativeOne Wealth LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $231,000. New Mexico Educational Retirement Board raised its stake in shares of HCA Healthcare by 29.9% during the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company's stock worth $4,636,000 after buying an additional 3,200 shares in the last quarter. Kingswood Wealth Advisors LLC acquired a new stake in HCA Healthcare in the first quarter valued at $566,000. Bessemer Group Inc. increased its holdings in shares of HCA Healthcare by 51.2% in the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company's stock valued at $2,543,000 after purchasing an additional 2,584 shares in the last quarter. Finally, Empowered Funds LLC boosted its holdings in HCA Healthcare by 54.3% during the first quarter. Empowered Funds LLC now owns 13,910 shares of the company's stock worth $4,639,000 after buying an additional 4,893 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company's stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company's stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock worth $6,407,273 in the last three months. 1.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

HCA has been the topic of several research analyst reports. Barclays boosted their price target on HCA Healthcare from $376.00 to $396.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 24th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. KeyCorp assumed coverage on shares of HCA Healthcare in a report on Friday, October 11th. They issued an "overweight" rating and a $475.00 price target on the stock. Royal Bank of Canada upped their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research note on Friday, August 23rd. Finally, Wells Fargo & Company upped their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an "equal weight" rating in a report on Tuesday, July 30th. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have assigned a strong buy rating to the stock. According to MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and an average target price of $365.65.

HCA Healthcare Trading Up 2.2 %

Shares of HCA Healthcare stock traded up $9.06 during trading hours on Friday, hitting $415.54. The company's stock had a trading volume of 1,093,996 shares, compared to its average volume of 1,139,995. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The company has a market capitalization of $108.84 billion, a PE ratio of 20.71, a P/E/G ratio of 1.44 and a beta of 1.67. The business has a fifty day moving average of $392.18 and a 200 day moving average of $350.34. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts' consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analysts' expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm's quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.29 earnings per share. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.64%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.